July 29th, 2010
Posted by Faraci Lange
Julie S. Jordan, an associate at Faraci Lange LLP, has been recognized with the Up and Coming Attorney Award from The Daily Record.
The award is given to attorneys who are active in the community, demonstrate a commitment to the community through activities or pro bono work, and who demonstrate leadership and above-average achievements in day-to-day legal assignments.
Jordan focuses her practice on medical malpractice, complex tort and toxic tort, premises liability, products liability and automotive negligence cases. She is a resident of Farmington, N.Y.
March 18th, 2009
Posted by Matthew F. Belanger, Partner, Faraci Lange
On March 4, 2009, the Supreme Court decided a case that has profound implications regarding the rights of consumers to sue prescription drug manufacturers for failing to properly warn of dangers of prescription drugs. In Wyeth v. Levine, ___ U.S. ___, 2009 U.S. LEXIS 1774 (U.S. Mar. 4, 2009) the Supreme Court ruled 6-3 that FDA approval of a prescription drug warning label does not always pre-empt state tort suits regarding the adequacy of such warnings. The decision comes as somewhat of a surprise because just last year, in Riegel v. Medtronic, 552 U.S. ___ (2008), the Supreme Court ruled 8-1 that FDA pre-market approval of Class III medical devices pre-empts state law negligence claims that challenge the safety or effectiveness of FDA-approved devices. The difference in outcome between Wyeth and Riegel is explained by an understanding of the different ways that Congressional actions can pre-empt state law. More…
